Graminex®, L.L.C.完成关注女性尿失禁问题的Graminex® Flower Pollen Extract临床试验,并获得积极结果

2022-08-03 网络 网络

初步分析表明,Graminex® Flower Pollen Extract研究小组在多项尿失禁生活质量指标方面出现明显改善。

Graminex®, L.L.C.欣然宣布,已针对女性尿失禁和泌尿系统健康完成了Graminex® Flower Pollen Extract临床研究,并获得积极结果。这项随机、双盲、安慰剂对照研究旨在调查Graminex® Flower Pollen Extract对190名尿失禁女性患者的有效性。初步分析表明,Graminex® Flower Pollen Extract研究小组在多项尿失禁生活质量指标方面出现明显改善。

多年来,业界一直在研究花粉提取物对女性更年期症状的效用。最近,Graminex®在女性健康的一个细分类别——尿失禁,特别是压力引起的急迫性尿失禁方面发现了花粉提取物的益处。尿失禁在产后女性以及更年期女性中更为突出。

首席商务官Colleen May表示:“大量妇女因尿失禁而导致生活质量下降。在这些研究结果的支持下,Graminex很高兴能提供一种天然替代产品,在最需要的时候改善女性的生活质量。”

关于Graminex® L.L.C.

Graminex® L.L.C.是天然及无溶剂Graminex® Flower Pollen Extract™的领先生产商。Graminex®在俄亥俄州西北部直接拥有和经营超过6,500英亩农场,以满足其客户的需求。Graminex种植、加工Graminex的活性成分,用于膳食补剂、营养品、药品、食品、皮肤护理行业。Graminex®营销其自有的膳食补剂产品线,侧重于前列腺健康、尿路健康、维护更年期健康和皮肤护理。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
    2022-09-18 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1657664, encodeId=8bdd165e6642c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun Sep 18 17:13:51 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763235, encodeId=fa901e632354c, content=<a href='/topic/show?id=b2591e7241b' target=_blank style='color:#2F92EE;'>#Tract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17724, encryptionId=b2591e7241b, topicName=Tract)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b2037445014, createdName=12498877m110暂无昵称, createdTime=Wed Apr 12 15:13:51 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785937, encodeId=51981e85937e6, content=<a href='/topic/show?id=b8c0e17672' target=_blank style='color:#2F92EE;'>#extract#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7176, encryptionId=b8c0e17672, topicName=extract)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Thu Jun 22 16:13:51 CST 2023, time=2023-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281696, encodeId=4cb41281696ee, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619136, encodeId=09fa16191360a, content=<a href='/topic/show?id=746244636ee' target=_blank style='color:#2F92EE;'>#女性尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44636, encryptionId=746244636ee, topicName=女性尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Aug 04 04:13:51 CST 2022, time=2022-08-04, status=1, ipAttribution=)]

相关资讯

J Urol:根治性前列腺切除术后新发储尿功能障碍是否常见?

评估了男性新发储尿功能障碍的流行率、自然史和风险因素。

BJU Int:根治性前列腺切除术后,哪些患者需要进行尿失禁手术干预?

调查了前列腺根治术后患者报告的尿失禁和困扰评分是否会导致随后的尿失禁手术干预。

EU :腹腔镜 VS 机器人 哪种方式进行根治性前列腺切除术更好?

根治性前列腺切除术(RP)后尿失禁深深地影响患者生活质量。机器人辅助根治性前列腺切除术(RARP)和腹腔镜RP (LRP)是常用的手术方式,研究显示它们对肿瘤治疗效果无差异,而前者对控尿更好。

Radiology:这一前列腺MRI测量值,可实现对前列腺切除术后尿失禁的无创预测!

根治性前列腺切除术(RP)后的尿失禁是决定患者生活质量的一个重要因素。在一项荟萃分析中,RP术后1年的尿失禁发生率为4%至31%。

Eur Urol Focus:人工尿道括约肌治疗术后应激性尿失禁的效果如何?

比较了PPI患者植入AUS后的尿失禁结果与BPO手术后植入AUS的尿失禁结果。

BMJ Support Palliat Care:电针治疗可有效改善老年女性的压力性尿失禁

EA可能是治疗老年和非老年妇女SUI或压力为主的MUI的有效和安全的替代疗法。年龄可能不会影响电针的治疗效果。

拓展阅读

【专家述评】| 2023年中国乳腺癌重要临床研究成果及最新进展

本文对2023年中国乳腺癌领域的重要临床研究进行回顾,总结关键结果,以期为未来的临床研究提供参考。

Clin. Cancer Res. | 饮食对乳腺癌预后的影响:临床试验证据和问题

该试验旨在研究为期5年的地中海式饮食和生活方式干预对意大利1524名I-III期乳腺癌患者复发的影响,饮食和体重对乳腺癌预后具有重要影响,研究支持乳腺癌幸存者遵循健康饮食以改善预后。

药物临床试验不良反应因果关系评价方法概述与存在问题的思考

目前,国际上对于临床试验期间的药物不良反应因果关系评价方法尚无统一标准,在实际工作中存在诸多问题与挑战。本文通过检索国内外文献,介绍了5种国内外较常用的因果关系评价方法和我国上市后药物不良反应因果关系

“长生不老药”烟酰胺的滑铁卢!Science子刊:综合25项临床试验发现,几乎没有效果

Science Advances:口服NR补充剂几乎没有临床相关效果,同时这些研究结果有“夸大”的嫌疑。

ENYO Pharma宣布完成3900万欧元的C轮融资,并获得FDA批准以推进Vonafexor治疗Alport综合征的二期临床试验

该公司将于2024年上半年启动Vonafexor治疗Alport综合征的二期临床研究(名为“ALPESTRIA-1”)。

Nature:临床试验将溶瘤免疫激活与胶质母细胞瘤的存活联系起来

本文结果为人类验证了病变内oHSV治疗增强了抗癌免疫反应,即使在免疫抑制肿瘤微环境中,特别是在注射病毒具有同源血清学的患者中。这为在对免疫治疗没有反应的癌症中使用这种溶瘤方式提供了生物学依据。

2023 NICE 临床指南:神经系统疾病中的尿失禁的评估和治疗[CG148]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-10-02

2020 NICE 医疗技术创新简报:快换式尿失禁包扎术治疗男性尿失禁【MIB237】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2020-11-24

尿失禁患者自我管理的最佳证据总结

同济大学医学院 · 2022-01-01